Mytochondria recycling therapy to boost children’s hearts
ANKIAL INNOVATION
Our medical treatment combats cardiomyopathies through mitochondria
Our Team
A team of researchers and specialists in hypertrophic cardiomyopathy
Rodrigue ROSSIGNOL
CEO
100 papers on mitochondrial research / 4 patents on mitochondrial pharmacology
Founder Cellomet Co-dir U1211
Nivea AMOEDO
COO
3 Years of experience in CRO Management
International program manager France-Brazil
>30 publications in mitochondrial biology / 1 patent in mitochondrial medicine
Didier LACOMBE
CMO
Daily consultation with rare diseases patients / 200 publications in rare diseases + 1 patent
Bruno LEGRAND
CTO
Head Cardiovascular Pierre Fabre / since 28 years (BMS, etc.) / Fillings by FDA/EMA
25 patents, 80+ publications
IP specialist negociations VCs
Our professional experiences
Our team has participated in research projects in various institutions